Small-Cap Stocks Are Crushing the S&P 500. This ETF Could Be the Smartest Buy of 2026

This is less a broad small-cap thesis than a factor regime call: if earnings revisions keep improving while funding costs stay contained, the market can finally reward balance-sheet-clean cyclicals and domestically focused businesses that have been trapped by higher discount rates. The biggest beneficiaries are likely the boring parts of small-cap value — regional financials, industrial suppliers, and select consumer names — where operating leverage can turn modest revenue growth into outsized EPS upside. That creates a second-order headwind for the mega-cap growth complex: even without absolute underperformance, relative multiple expansion in high-duration names becomes harder if breadth keeps widening.

The main risk is that the forecasted earnings acceleration is fragile and heavily dependent on stable credit conditions. Small caps tend to look strongest just before financing becomes restrictive; a 25-50 bps backup in the 10Y or a widening in high-yield spreads would hit them faster than large caps because of higher refinancing and working-capital sensitivity. If the rally is being driven by positioning rather than true revisions, it can reverse quickly over days to weeks; if revisions hold, the more meaningful re-rating window is 1-3 months, with structural breadth improvement taking 6-18 months.

The contrarian view is that the market may be over-rotating from years of underperformance into a clean, linear catch-up narrative. A 14x forward multiple is not cheap if the earnings base is still low quality, and many small-cap value screens include businesses with cyclical earnings spikes rather than durable compounding power. The key falsifier is simple: if small-cap EPS revisions flatten while rates move up, the valuation support disappears and this becomes a short-lived factor trade rather than a structural shift.